BioSET

company

About

BioSET develops therapeutic peptide-based medical devices to improve bone and soft tissue repair.

  • 51 - 100

Details

Last Funding Type
Series A
Industries
Biotechnology,Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 2001
Number Of Employee
51 - 100
Operating Status
Active

BioSurface Engineering Technologies, Inc., also known as BioSET, engages in developing proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair. The company focuses on developing devices for orthobiologics applications. Its products include AMPLEX, an implantable combination device of the B2A peptide and a synthetic ceramic scaffold for use as a surgical bone graft implant for lumbar degenerative disc disease, as well as for use in spine, cervical spine, and foot and ankle fusion surgeries. The company also develops products for sports medicine applications based on its F2A peptide; and peptide signaling molecules and various scaffold biomaterials for use in musculoskeletal applications, including trauma, fracture repair, and other soft tissue treatments. BioSurface Engineering Technologies, Inc. was founded in 2001 and is based in Rockville, Maryland.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$16M
BioSET has raised a total of $16M in funding over 2 rounds. Their latest funding was raised on Jun 5, 2007 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 5, 2007 Series Unknown $11M 1 Detail
Aug 5, 2004 Series B $5M 1 Detail
Mar 13, 2002 Series A 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
BioSET is funded by 2 investors. The New Markets Growth Fund and Boston Scientific are the most recent investors.
Investor Name Lead Investor Funding Round
The New Markets Growth Fund Series Unknown
Boston Scientific Series A